HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antibiotic chemotherapy of bacterial sexually transmitted diseases in adults: a review.

Abstract
Treatment regimens for sexually transmitted infections continue to evolve. The natural history of syphilis in HIV-infected patients is leading to more aggressive policies in terms of both investigation and treatment. In particular, treatment protocols for late syphilis, especially neurosyphilis, are under scrutiny. Epidemiological change typified by the spread of penicillinase-producing Neisseria gonorrhoeae (PPNG) has led to a search for new agents to treat gonorrhoea, with a more extensive use of cephalosporin and quinolone antibiotics emerging. The problem of compliance with the antibiotic courses presently required for chlamydial infection may be close to being solved with the development of newer macrolide agents. Single dose azithromycin, although expensive, seems to be as effective as longer courses with other agents. Furthermore, its efficacy in gonococcal infection is also encouraging. Increased understanding of the pathogenesis and natural history of pelvic inflammatory disease (PID) and bacterial vaginosis (BV) has led to rationalization of treatment policies for these conditions.
AuthorsG D Corcoran, G L Ridgway
JournalInternational journal of STD & AIDS (Int J STD AIDS) 1994 May-Jun Vol. 5 Issue 3 Pg. 165-71 ISSN: 0956-4624 [Print] England
PMID8061086 (Publication Type: Journal Article, Review)
Chemical References
  • Anti-Bacterial Agents
Topics
  • Adult
  • Anti-Bacterial Agents (therapeutic use)
  • Female
  • Gonorrhea (drug therapy)
  • HIV Infections (complications)
  • Humans
  • Male
  • Pelvic Inflammatory Disease (drug therapy)
  • Pregnancy
  • Pregnancy Complications, Infectious (drug therapy)
  • Sexually Transmitted Diseases, Bacterial (drug therapy)
  • Syphilis (complications, drug therapy)
  • Urethritis (drug therapy)
  • Vaginosis, Bacterial (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: